title: The development of evidence-based supportive therapy guidelines for symptom management.
abstract: Systematic incorporation of toxicity assessment and grading during cancer treatment and subsequent provision of evidence-based patient interventions according to national standards for excellence are daunting tasks. To accomplish those goals, the authors' institution developed evidence-based supportive therapy guidelines for symptom management. This article describes how the guidelines provided concise, user-friendly standardization of toxicity grading and immediate clinical application of evidence-based care.
authors: John Theurer Cancer Center, Hackensack University Medical Center in New Jersey, USA. mweber@humed.com
authors: Melinda S
authors: MS
authors: Weber
authors: Greg
authors: G
authors: Eskinazi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000451:nursing* / Q000628:therapy; D019317:Evidence-Based Medicine / Q000458:organization & administration*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing*; D009723:Nurse-Patient Relations; D017410:Practice Guidelines as Topic; D016730:Program Development; D015397:Program Evaluation; D011786:Quality Control; D012720:Severity of Illness Index
chemical_list: D000970:Antineoplastic Agents